Clinical trial
A Multicenter, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma
NCT00472108 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma
- Lead sponsor
- Galderma R&D
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2000
- Completion date
- April 30, 2002
- Enrollment
- 65 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.